CMS Prior Authorization Reform Will Expose the Weak Links in Your Operating Model
What health plan and provider executives should change now to reduce access friction, rework, and uncontrolled AI risk
CMS-0057-F changes the operating context for impacted payers and for the provider organizations that serve their members. Beginning in 2026, affected payer types face requirements for faster non-drug prior authorization decisions, specific denial reasons, and public reporting. API requirements generally begin in 2027 and make coverage requirements, documentation needs, requests, and responses more machine-readable (Centers for Medicare & Medicaid Services [CMS], 2024). That makes prior authorization an operating-model decision, not simply a technology project. When incomplete documentation, unclear decision rights, and fragmented handoffs enter a more automated workflow, organizations do not eliminate friction. They move it into denials, resubmissions, appeals, staff overload, and delayed care. Artificial intelligence can help, but it can also accelerate inconsistency when roles, governance, and quality controls remain undefined.
Executive Takeaways
Prior authorization reform is now a workflow, workforce, and governance decision, not an API installation.
Use AI to assist routine work. Preserve accountable clinical review when outputs can influence care or coverage.
Fund against access, quality, capacity, utilization, and control risk. Faster output is not enough.
Regulatory scope to keep straight.
CMS-0057-F applies to Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan issuers on the Federally Facilitated Exchanges. It addresses non-drug prior authorization. Exact compliance dates vary by payer type, and the 72-hour expedited and seven-calendar-day standard decision timeframes exclude QHP issuers on the FFEs (CMS, 2024).
Decision 1: Move documentation readiness upstream
The business decision is whether to keep treating prior authorization as a back-office recovery process or design for a clean request at the point of care. APIs and workflow automation expose missing evidence, inconsistent medical-policy translation, or incomplete clinical context quickly. The result may be a faster clean submission, or a faster rejection, clarification loop, or appeal.
For providers, connect ordering, referral, scheduling, clinical operations, revenue cycle, and informatics from the moment an order is placed. Give clinicians simple, policy-aware job aids and access to trained documentation support for complex cases. For health plans, connect policy owners, UM clinicians, provider experience, compliance, product/API teams, and operations around a common policy-to-workflow model.
In one quality-improvement study of 6,551 radiation oncology cases, a clinically integrated workflow was associated with a 65.4% reduction in initial denials and a reduction in median authorization time from 4.2 to 2.8 business days (Chen et al., 2025). The study does not guarantee a universal return, but it shows the value of early visibility into requirements and missing information.
Decision 2: Separate assistive AI from AI that influences care or coverage
The more consequential decision is which work AI may assist, which work it may recommend, and where people retain authority. Start with assistive AI: retrieving documentation, prepopulating templates, identifying missing elements, summarizing records for reviewers, classifying denial reasons, forecasting queues, and spotting handoff failures. These uses reduce searching and rework without transferring clinical accountability to a model.
Apply stronger controls when AI can shape a medical-necessity rationale, prioritize exceptions, draft provider or member communications, or recommend approval or denial. Lenert et al. (2023) argue that human-centered AI for prior authorization needs transparency, expert validation, patient representation, and continuing bias review. The NIST AI Risk Management Framework adds practical discipline: govern the use case, map context and potential harm, measure performance, and manage findings over time (National Institute of Standards and Technology [NIST], 2023).
For COOs and UM leaders, five controls matter: approved source data; advisory versus determinative outputs; required human review thresholds; override and escalation paths; and traceable audits of errors, drift, and outcomes.
Decision 3: Redesign roles and capacity around the future workflow
Adding staff to the existing queue may stabilize volume, but it preserves the labor model that created the backlog. CHROs and operating leaders should redesign roles around the end-to-end value stream.
Routine eligibility and status work can be supported by standardized exchange, automation, and clear work instructions. Point-of-care data synthesis needs staff who understand clinical context, documentation standards, payer requirements, and how to resolve a missing element without disrupting care. Complex exceptions and appeals require judgment from clinical reviewers, coders, medical directors, and compliance partners. A small governance group should own policy translation, AI quality assurance, role-based training, and continuous improvement.
Workforce planning should follow workflow design, not historical job titles. Healthcare transformation research supports whole-system role and skill planning, early stakeholder dialogue, and adaptive learning structures when work changes across organizational boundaries (Pittman & Scully-Russ, 2016). Leaders should also test whether predictable, consistently appropriate requests can move to lower-friction pathways, targeted audit, proactive authorization, or negotiated exemptions rather than applying the same prospective review to every request (Psotka et al., 2020).
For CHROs, that means new proficiency standards, learning pathways, and staffing ratios. For CFOs, it means asking where capacity can be recovered before rework becomes denial and appeal volume.
What COOs, CHROs, CFOs, and UM leaders should do differently
Decision 4: Fund and govern against access, control, and capacity
Inaction has two costs. The first is operational: delayed care, resubmissions, appeal volume, clinician interruption, provider abrasion, and revenue leakage. The second is governance-related: teams adopt different AI tools, prompts, sources, and quality checks, leaving leaders unable to explain why a recommendation, request, or communication was produced.
The access risk is not theoretical. The HHS Office of Inspector General found that 13% of denied Medicare Advantage prior authorization requests in its sample met Medicare coverage rules, meaning the denials likely prevented or delayed medically necessary care (Office of Inspector General [OIG], 2022). This does not mean utilization management lacks value. It means leaders must distinguish appropriate review from avoidable administrative friction.
CFOs should track cost per clean request, cycle time, first-pass completeness, rework, appeals and reversals, capacity recovered, compliance exposure, staff workload, and access outcomes by service line and population. Kyle and Song (2023) caution that electronic prior authorization will not automatically create savings and may have unintended utilization effects. Faster output or a higher approval rate alone does not prove better performance.
The Xerebral READY+ Workforce Friction Map
Xerebral’s READY+ Workforce Friction Map combines a readiness diagnostic with a work-allocation test. READY+ examines Roles and workflows; Enablement and skills; API, data, and AI controls; Decision governance and human oversight; and Yield, quality, and equity. The friction map then asks which work is routine enough to automate, which needs informed documentation support, and which requires accountable clinical judgment.
Score each condition from 1 to 5 for a high-volume or high-risk pathway. Use the work-allocation table below to locate the constraint before selecting technology, changing staffing, or launching a pilot.
Work Allocation Test
Why Xerebral
Xerebral brings healthcare workforce strategy, organization and role design, HR technology, people analytics, learning design, and executive operating routines to one problem. We help leaders connect policy, workflow, data, capability, automation, and measurable performance so clinical judgment remains visible as automation expands.
What to do in the next 90 days
Days 1-30: Map the five highest-volume or highest-risk pathways. Baseline demand, cycle time, clean-submission rate, rework, appeals, workload by role, and reasons cases leave the standard path. Inventory automation and AI use, including sources, outputs, review points, and owners.
Days 31-60: Design one future-state pathway. Define service tiers, documentation standards, AI use cases, role accountabilities, escalation rules, clinical decision rights, quality checks, and measures that trigger correction. Build role-based training and job aids.
Days 61-90: Pilot one payer-service-line or specialty pathway. Review throughput, error types, workload, access indicators, and equity signals weekly. Scale only after the pilot improves outcomes, not merely speed.
Assess your workforce readiness. Before committing to an AI prior authorization vendor, major build, or additional staffing, download the Prior Authorization Readiness Checklist for the Workforce. It identifies the immediate constraint and a practical first move.
Source note. The final rule’s specific implementation and compliance obligations differ by payer type, program, and contractual arrangement. This article provides an operating-model perspective for executive planning and does not provide legal advice.
References
Centers for Medicare & Medicaid Services. (2024, January 17). CMS interoperability and prior authorization final rule (CMS-0057-F) [Fact sheet]. https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-prior-authorization-final-rule-cms-0057-f
Chen, W. C., Carpenter, C., Sidiqi, B., Pattison, A. J., Hwang, J., Pappas, D., & Potters, L. (2025). Integrating prior authorization into clinical workflows for care access and practitioner experience. JAMA Network Open, 8(12), e2549093. https://doi.org/10.1001/jamanetworkopen.2025.49093
Kyle, M. A., & Song, Z. (2023). The consequences and future of prior-authorization reform. New England Journal of Medicine, 389(4), 291-293. https://doi.org/10.1056/NEJMp2304447
Lenert, L. A., Lane, S., & Wehbe, R. (2023). Could an artificial intelligence approach to prior authorization be more human? Journal of the American Medical Informatics Association, 30(5), 989-994. https://doi.org/10.1093/jamia/ocad016
National Institute of Standards and Technology. (2023). Artificial intelligence risk management framework (AI RMF 1.0) (NIST AI 100-1). https://doi.org/10.6028/NIST.AI.100-1
Office of Inspector General, U.S. Department of Health and Human Services. (2022). Some Medicare Advantage Organization denials of prior authorization requests raise concerns about beneficiary access to medically necessary care (OEI-09-18-00260). https://oig.hhs.gov/oei/reports/OEI-09-18-00260.pdf
Pittman, P., & Scully-Russ, E. (2016). Workforce planning and development in times of delivery system transformation. Human Resources for Health, 14, 56. https://doi.org/10.1186/s12960-016-0154-3
Psotka, M. A., Singletary, E. A., Bleser, W. K., Roiland, R. A., Hamilton Lopez, M., Saunders, R. S., Wang, T. Y., McClellan, M. B., Brown, N., & American Heart Association Prior Authorization Learning Collaborative. (2020). Streamlining and reimagining prior authorization under value-based contracts: A call to action from the Value in Healthcare Initiative’s Prior Authorization Learning Collaborative. Circulation: Cardiovascular Quality and Outcomes, 13(7), e006564. https://doi.org/10.1161/CIRCOUTCOMES.120.006564